original ) (raw )Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients
Vishal Bansal
Journal of Trauma and Acute Care Surgery, 2013
View PDFchevron_right
Anti-Xa–guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients
enrique ginzburg
Journal of Trauma and Acute Care Surgery, 2016
View PDFchevron_right
Anti-Factor Xa measurements in acute care surgery patients to examine enoxaparin dose
Nick Lonardo
American journal of surgery, 2017
View PDFchevron_right
Anti-Factor Xa Activity of Prophylactic Enoxaparin Regimens in Critically Ill Patients
Moshe Hersch
2016
View PDFchevron_right
Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
Gee Young Suh
Journal of Korean Medical Science, 2013
View PDFchevron_right
Factor Xa Levels in Patients Receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital
Shahed Omar
Indian Journal of Critical Care Medicine, 2021
View PDFchevron_right
Pharmacokinetics and Pharmacodynamics of Enoxaparin in Multiple Trauma Patients
William Mihalko
The Journal of Trauma: Injury, Infection, and Critical Care, 2005
View PDFchevron_right
Determination of Optimal Weight-Based Enoxaparin Dosing and Associated Clinical Factors for Achieving Therapeutic Anti-Xa Assays for Deep Venous Thrombosis Prophylaxis
J Bethea
Journal of the American College of Surgeons, 2019
View PDFchevron_right
Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
Thomas Strøm
Critical Care, 2010
View PDFchevron_right
Implementation of an Enoxaparin Protocol for Venous Thromboembolism Prophylaxis in Obese Surgical Intensive Care Unit Patients
Richard Barton
Annals of Pharmacotherapy, 2011
View PDFchevron_right
Goal directed enoxaparin dosing provides superior chemoprophylaxis against deep vein thrombosis
Tammy kopelman
Injury, 2017
View PDFchevron_right
Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit
Aliakbar Keykha
Archives of Anesthesia and Critical Care, 2020
View PDFchevron_right
Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial
Kalina Kavaldzhieva
JAMA surgery, 2016
View PDFchevron_right
Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning
Minion Pé
Journal of Vascular Surgery, 2001
View PDFchevron_right
The Effect of Postoperative Enoxaparin on Risk for Reoperative Hematoma
Loree K. Kalliainen , Andrea Pusic
View PDFchevron_right
WEIGHT-BASED DOSING OF ENOXAPARIN AND ANTIFACTOR XA LEVELS FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN MEDICALLY-ILL PATIENTS
Asian Journal of Pharmaceutical and Clinical Research Journal
Asian Journal of Pharmaceutical and Clinical Research, 2022
View PDFchevron_right
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels
Fred Leya
Thrombosis Research, 2003
View PDFchevron_right
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Maya Thrasher
Thrombosis Journal
View PDFchevron_right
Benefits and Risks of Preventing Thromboembolism With Enoxaparin in Patients With General Surgery in Real World—The CLEVER Study
Sylvia Haas
Clinical and Applied Thrombosis/Hemostasis, 2012
View PDFchevron_right
Improving Pharmacologic Prevention of VTE in Trauma: IMPACT-IT QI Project
J Bethea
The American Surgeon, 2018
View PDFchevron_right
Enoxaparin and Antifactor Xa Levels in Acute Burn Patients
Iris Faraklas
Journal of Burn Care & Research, 2011
View PDFchevron_right
Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
PIPPA ANDERSON
Pharmacy World & Science, 2000
View PDFchevron_right
Thromboprophylaxis in Patients undergoing Orthopedic Surgeries; Focus on cost-effective analysis and safety comparison between Rivaro Rivaroxaban and Enoxaparin
Emad Gaber
2017
View PDFchevron_right
Body Weight Does Not Predict for Anti-Xa Levels after Fixed Dose Prophylaxis with Enoxaparin After Orthopedic Surgery
Karen MacKinnon , Michael Keeney
Thrombosis Research, 1998
View PDFchevron_right
Prevention of venous thromboembolism after surgery: A review of enoxaparin
Amir Jaffer
British Journal of Surgery, 1992
View PDFchevron_right
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
Ali Altebainawi
Thrombosis Journal, 2022
View PDFchevron_right
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
Emmanuel Andrès
… England Journal of …, 1999
View PDFchevron_right
Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition
Zung Tran , Paul Wischmeyer
Intensive Care Medicine, 2012
View PDFchevron_right
Inability to predict subprophylactic anti–factor Xa levels in trauma patients receiving early low-molecular-weight heparin
Paul Rizk
Journal of Trauma and Acute Care Surgery, 2018
View PDFchevron_right
Impact of augmented renal clearance on enoxaparin therapy in critically ill patients
Mohamed Naeem
View PDFchevron_right
Prevention of Venous Thromboembolism Using Enoxaparin in Day Surgery
Sylvia Haas
Clinical and Applied Thrombosis/Hemostasis, 2011
View PDFchevron_right
Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant
Kaname Nakatani
Thrombosis Journal
View PDFchevron_right
Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis
Paola Sánchez
British Journal of Clinical Pharmacology, 2005
View PDFchevron_right
Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
Jeffrey Salomone
The American Journal of Surgery, 2013
View PDFchevron_right